China Pharma Holdings (CPHI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 10,924 | 12,331 | 13,212 | 15,571 | 20,352 |
| Cost of Goods | 9,442 | 10,356 | 10,744 | 12,352 | 18,887 |
| Gross Profit | 1,482 | 1,975 | 2,469 | 3,219 | 1,465 |
| Operating Expenses | 22,332 | 12,778 | 21,892 | 11,726 | 16,652 |
| Operating Income | -20,408 | -10,447 | -18,680 | -8,156 | -14,300 |
| Interest Expense | 322 | 451 | 539 | 850 | 1,165 |
| Other Income | 28 | 39 | 64 | 131 | 120 |
| Pre-tax Income | -20,702 | -10,860 | -19,155 | -8,874 | -15,345 |
| Income Tax | N/A | -110 | 123 | 308 | 60 |
| Net Income Continuous | -20,702 | -10,750 | -19,278 | -9,183 | -15,406 |
| Net Income | $-20,702 | $-10,750 | $-19,278 | $-9,183 | $-15,406 |
| EPS Basic Total Ops | -240.00 | -125.00 | -220.00 | -105.00 | -175.00 |
| EPS Basic Continuous Ops | -237.52 | -123.34 | -221.17 | -105.35 | -176.75 |
| EPS Diluted Total Ops | -240.00 | -125.00 | -220.00 | -105.00 | -175.00 |
| EPS Diluted Continuous Ops | -237.52 | -123.34 | -221.17 | -105.35 | -176.75 |
| EPS Diluted Before Non-Recurring Items | -240.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-17,479 | $-7,189 | $-15,389 | $-5,077 | $-10,701 |